Trademark: 79211994
Word
NEOONSITE
Status
Registered
Status Code
700
Status Date
Tuesday, January 9, 2018
Serial Number
79211994
Registration Number
5372317
Registration Date
Tuesday, January 9, 2018
Mark Type
4000
Filing Date
Wednesday, January 25, 2017
Published for Opposition
Tuesday, October 24, 2017

Trademark Owner History
Siemens Healthcare GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; * diagnostic preparations for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases * [ diagnostic preparations for medical purposes ] ; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection [, ] * and * analysis [ and treatment ] of cancer; cultures of microorganisms for medical and veterinary use *, namely, for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases *
44 Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases
42 Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software
In the Statement, class 5 has been corrected per the Restriction dated 8/30/18, and per the Fnote dated 10/3/18.
NEO ON-SITE
NEO ON SITE
In the statement, " International class 5 " is corrected per the restriction and the fnote dated 1/29/2019.

Trademark Events
Jan 9, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 24, 2021
New Representative At Ib Received
Dec 3, 2019
Invalidation Reviewed - No Action Required By Office
Nov 13, 2019
Partial Invalidation Of Reg Ext Protection Created
Mar 6, 2019
Limitation From The Ib Examined And Entered
Mar 6, 2019
Correction Under Section 7 ¿ Processed
Mar 6, 2019
Case Assigned To Post Registration Paralegal
Nov 16, 2018
Limitation Of Goods Received From Ib
Oct 5, 2018
Correction Under Section 7 ¿ Processed
Oct 3, 2018
Limitation From The Ib Examined And Entered
Aug 31, 2018
Limitation Of Goods Received From Ib
May 25, 2018
Final Decision Transaction Processed By Ib
Apr 17, 2018
Final Disposition Notice Sent To Ib
Apr 17, 2018
Final Disposition Processed
Apr 9, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jan 9, 2018
Registered-Principal Register
Oct 24, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2017
Published For Opposition
Oct 21, 2017
Notification Processed By Ib
Oct 4, 2017
Notification Of Possible Opposition Sent To Ib
Oct 4, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 4, 2017
Notification Of Notice Of Publication E-Mailed
Sep 20, 2017
Approved For Pub - Principal Register
Sep 20, 2017
Examiner's Amendment Entered
Sep 20, 2017
Notification Of Examiners Amendment E-Mailed
Sep 20, 2017
Examiners Amendment E-Mailed
Sep 20, 2017
Examiners Amendment -Written
Aug 31, 2017
Teas/Email Correspondence Entered
Aug 31, 2017
Correspondence Received In Law Office
Aug 29, 2017
Assigned To Lie
Aug 25, 2017
Refusal Processed By Ib
Aug 10, 2017
Teas Response To Office Action Received
Aug 9, 2017
Teas Response To Office Action Received
Aug 4, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Aug 3, 2017
Refusal Processed By Mpu
Aug 1, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 31, 2017
Non-Final Action Written
Jul 26, 2017
Non-Final Action (Ib Refusal) Withdrawn For Review
Jul 22, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 21, 2017
Non-Final Action Written
Jul 18, 2017
Application Filing Receipt Mailed
Jul 14, 2017
Assigned To Examiner
Jul 14, 2017
New Application Office Supplied Data Entered In Tram
Jul 13, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24